Skip to main content

BATM Advanced Communications Ltd. (BVC.L)

London Stock Exchange Healthcare Medical - Instruments & SuppliesView data quality →
42.0Fair

ValueMarkers Composite Index

Top 9%#40,552 of 44,707
Undervalued

33% below intrinsic value ($19)

UndervaluedFair ValueOvervalued
Piotroski
4/9
Neutral
Beneish
-2.59
Low Risk
Altman
-1.14
Distress
DCF Value
$19
Undervalued
ROIC
-4.4%
Low
P/E
-
Updated: ·Source: Data sourced from SEC filings and institutional providers. Not financial advice.·Report data issue

BATM Advanced Communications Ltd. (BVC.L) — VMCI valuation read

Composite valuation read on BVC.L: VMCI 42/100 against a Healthcare sector median of 50. The 8-point below-median print is the headline number for BATM Advanced Communications Ltd., and at the mid-cap tier it reflects how the five pillars combine into a single decision-grade score.

Trailing 30-day insider activity for BVC.L: nothing material on SEC EDGAR. With the Form 4 channel quiet, the price-vs-DCF gap and the trailing margin trend carry more weight in the active read.

**Investor frame.** Value, quality, risk in three lines on BVC.L: BVC.L trades at 15.0x earnings, 17% below the Healthcare median of 18.0x; ROIC of 13.0% sits 3.0pp above the Healthcare median (10.0%); net debt to EBITDA of -2.2x leaves covenant headroom. EV/EBITDA at 14.0x versus 12.0x for Healthcare closes the value frame.

BVC.L fell 3.8% over the trailing 7 days, with a -1.6% read on a 30-day basis.

BATM Advanced Communications Ltd., together with its subsidiaries, provides real-time technologies for networking solutions and bio-medical systems in Israel, the United States, and Europe. It operates in Networking and Cyber, and Bio-Medical divisions. The Networking and Cyber division is involved in the research and development, production, and marketing of data communication products, including network function virtualization, carrier ethernet and MPLS access solutions, and cyber network monitoring. It also offers software services, such as training and technical support, laboratory service and maintenance; and construction contracts. The Bio-Medical division engages in the research and development, production, marketing, and distribution of medical products, such as laboratory diagnostics and sterilization equipment. This division offers molecular biology diagnostics; provides solutions to treat pathogenic and medical waste in laboratories and hospitals, as well as for pharmaceutical manufacturing plants and agricultural applications; and distributes diagnostic equipment and medical supplies of various brands. BATM Advanced Communications Ltd. has a collaboration with Novamed Ltd for the joint development and marketing of a home-use testing kit for COVID-19. The company was founded in 1992 and is headquartered in Hod Hasharon, Israel.

CEO: Moti Nagar867 employeesILwww.batm.com

Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.

Browse More

Key metrics explained

Definitions, formulas, and how ValueMarkers calculates each indicator used in BVC.L’s VM Score.

Explore More

Compare Competitors

Weekly Stock Analysis - Free

5 undervalued stocks, fully modeled. Every Monday. No spam.

Cookie Preferences

We use cookies to analyze site usage and improve your experience. You can accept all, reject all, or customize your preferences.